Ra Medical Systems, Inc. (NYSE: RMED)
FILL OUT THE FORM TO FIND OUT YOUR INVESTOR RIGHTS TO POTENTIAL COMPENSATION »
Hagens Berman Sobol Shapiro LLP alerts investors in Ra Medical Systems, Inc. (NYSE: RMED) to the June 10, 2019 Lead Plaintiff deadline in the securities class action pending in the U.S. District Court for the Southern District of California.
If you purchased or otherwise acquired securities of RMED pursuant or traceable to the September 26, 2018 IPO and suffered losses you do not need to sign up to be included in the putative class of investors. If you suffered losses and wish to serve as lead plaintiff – one who selects and oversees the attorneys prosecuting the case – contact Hagens Berman Sobol Shapiro LLP. For more infomation contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing RMED@hbsslaw.com.
According to the complaint, Ra Medical’s Registration Statement in connection with the Company’s September 26, 2018 Initial Public Offering (“IPO”) misrepresented and concealed sales personnel issues and problems in the Company’s manufacturing process for catheters.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.